EA200702197A1 - Противораковая комбинация, содержащая производные замещённого акрилоилдистамицина и антитела, ингибирующие факторы роста или их рецепторы - Google Patents

Противораковая комбинация, содержащая производные замещённого акрилоилдистамицина и антитела, ингибирующие факторы роста или их рецепторы

Info

Publication number
EA200702197A1
EA200702197A1 EA200702197A EA200702197A EA200702197A1 EA 200702197 A1 EA200702197 A1 EA 200702197A1 EA 200702197 A EA200702197 A EA 200702197A EA 200702197 A EA200702197 A EA 200702197A EA 200702197 A1 EA200702197 A1 EA 200702197A1
Authority
EA
Eurasian Patent Office
Prior art keywords
tractic
acryloeldystamicine
receptors
substituted
growth factors
Prior art date
Application number
EA200702197A
Other languages
English (en)
Other versions
EA011574B1 (ru
Inventor
Энрико Песенти
Марина Чиомеи
Мария Кристина Джерони
Original Assignee
НЕРВИАНО МЕДИКАЛ САЙЕНСИЗ С.р.л.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by НЕРВИАНО МЕДИКАЛ САЙЕНСИЗ С.р.л. filed Critical НЕРВИАНО МЕДИКАЛ САЙЕНСИЗ С.р.л.
Publication of EA200702197A1 publication Critical patent/EA200702197A1/ru
Publication of EA011574B1 publication Critical patent/EA011574B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/39558—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against tumor tissues, cells, antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Настоящее изобретение относится к комбинированному применению в лечении опухолей производных акрилоилдистамицина, в частности производных α-бром- и α-хлоракрилоилдистамицина формулы (I), как изложено в описании изобретения, и антитела, ингибирующего фактор роста или его рецептор. Также описано применение упомянутых комбинаций в лечении или профилактике метастазов или в лечении опухолей путем ингибирования ангиогенеза.
EA200702197A 2005-04-08 2006-03-29 Противораковая комбинация, содержащая производные замещённого акрилоилдистамицина и антитела, ингибирующие факторы роста или их рецепторы EA011574B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05102792 2005-04-08
PCT/EP2006/061153 WO2006108763A1 (en) 2005-04-08 2006-03-29 Antitumor combination comprising substituted acryloyl distamycin derivatives and antibodies inhibiting growth factors or their receptors

Publications (2)

Publication Number Publication Date
EA200702197A1 true EA200702197A1 (ru) 2008-02-28
EA011574B1 EA011574B1 (ru) 2009-04-28

Family

ID=36624474

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200702197A EA011574B1 (ru) 2005-04-08 2006-03-29 Противораковая комбинация, содержащая производные замещённого акрилоилдистамицина и антитела, ингибирующие факторы роста или их рецепторы

Country Status (20)

Country Link
US (1) US20090074757A1 (ru)
EP (1) EP1868599B1 (ru)
JP (1) JP2008534649A (ru)
CN (1) CN101141955A (ru)
AT (1) ATE447950T1 (ru)
AU (1) AU2006233856A1 (ru)
BR (1) BRPI0607499A2 (ru)
CA (1) CA2598578A1 (ru)
CY (1) CY1109782T1 (ru)
DE (1) DE602006010349D1 (ru)
DK (1) DK1868599T3 (ru)
EA (1) EA011574B1 (ru)
ES (1) ES2335805T3 (ru)
HR (1) HRP20090617T1 (ru)
MX (1) MX2007010525A (ru)
PL (1) PL1868599T3 (ru)
PT (1) PT1868599E (ru)
RS (1) RS51231B (ru)
SI (1) SI1868599T1 (ru)
WO (1) WO2006108763A1 (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2868791A1 (en) * 2012-03-30 2013-10-03 The Regents Of The University Of California Anti-emp2 therapy reduces cancer stem cells
US10385395B2 (en) 2012-04-11 2019-08-20 The Regents Of The University Of California Diagnostic tools for response to 6-thiopurine therapy
CN109966499A (zh) * 2019-04-25 2019-07-05 苏州大学 协同增效的抗乳腺癌转移药物组合物及其用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5165922A (en) * 1990-05-22 1992-11-24 Bristol-Myers Squibb Company Synergistic tumor therapy with combinations of biologically active anti-tumor antibodies and chemotherapy
US6150508A (en) * 1996-03-25 2000-11-21 Northwest Biotherapeutics, Inc. Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen
KR20040078118A (ko) * 2002-01-02 2004-09-08 파마시아 이탈리아 에스.피.에이. 치환된 아크릴로일 디스타마이신 유도체 및 단백질 키나제(세린/트레오닌 키나제) 저해제를 포함하는 항종양 조합요법
CA2481005C (en) * 2002-04-02 2009-06-09 Pharmacia Italia S.P.A. Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and radiotherapy

Also Published As

Publication number Publication date
BRPI0607499A2 (pt) 2009-06-13
RS51231B (sr) 2010-12-31
DK1868599T3 (da) 2010-02-15
HRP20090617T1 (hr) 2009-12-31
EP1868599B1 (en) 2009-11-11
US20090074757A1 (en) 2009-03-19
MX2007010525A (es) 2008-01-16
PL1868599T3 (pl) 2010-04-30
JP2008534649A (ja) 2008-08-28
ES2335805T3 (es) 2010-04-05
SI1868599T1 (sl) 2010-01-29
WO2006108763A1 (en) 2006-10-19
EA011574B1 (ru) 2009-04-28
AU2006233856A1 (en) 2006-10-19
EP1868599A1 (en) 2007-12-26
PT1868599E (pt) 2010-01-26
CN101141955A (zh) 2008-03-12
ATE447950T1 (de) 2009-11-15
DE602006010349D1 (de) 2009-12-24
CY1109782T1 (el) 2014-09-10
CA2598578A1 (en) 2006-10-19

Similar Documents

Publication Publication Date Title
BRPI0510177B8 (pt) composto, composição farmacêutica e uso do mesmo
EA200701853A1 (ru) Производные циклопентапиридина и тетрагидрохинолина
ATE554087T1 (de) Neue kinaseinhibitoren
EA201000558A1 (ru) Производные имидазола
EA200701396A1 (ru) Триазолофталазины в качестве ингибиторов pde-2
TW200624426A (en) BACE inhibitors
EA200801291A1 (ru) Карбониламинопирролопиразолы в качестве эффективных ингибиторов киназ
ATE512151T1 (de) Pyrrolotriazin-kinaseinhibitoren
EA200970207A1 (ru) Соединения пиридо[2,3-d]пиримидинона и их применение в качестве pi3 ингибиторов
EA200901611A1 (ru) Производные 2-оксо-3-бензил-бензоксазол-2-она и родственные соединения в качестве ингибиторов мет киназы для лечения опухолей
EA200970156A1 (ru) Пиридизиноновые производные
EA200801428A1 (ru) Производные пиридиазинона для лечения опухолей
ATE527253T1 (de) Pyrimidin-substituierte benzimidazolderivate als proteinkinasehemmer
EA201170590A1 (ru) Ингибиторы рецептора фактора роста фибробластов-3 (fgfr-3) и способы лечения
WO2007047646A3 (en) Substituted dihydro-isoindolones useful in treating kinase disorders
EA201000550A1 (ru) Производные тиазола
ATE467632T1 (de) Pyrroloä2,3-büpyridinderivate als modulatoren des h3-rezeptors
EA200801414A1 (ru) Кальцилитические соединения
EA201000814A1 (ru) 5-[(3,3,3-трифтор-2-гидрокси-1-арилпропил)амино]-1h-хинолин-2-оны, способ их получения и их применение в качестве противовоспалительных средств
EA201000618A1 (ru) 5-цианотиенопиридины для лечения опухолей
EA200701676A1 (ru) Производные дигидроимидазотиазола
EA200800070A1 (ru) Производные 2-(1h-индолилсульфанил)ариламина
DE602006021327D1 (de) Isochinoline als igf-1r-inhibitoren
ATE542796T1 (de) N-sulfonylcarboximidamidverbindungen als apoptosepromotoren
ATE411287T1 (de) Neue metallproteinaseinhibitoren

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU